Literature DB >> 20414534

[Cardiometabolic abnormalities in patients with Berardinelli-Seip syndrome].

Antonio Guedes do Rêgo1, Evandro Tinoco Mesquita, Carlos Alberto de Faria, Marcel Alvares Guedes do Rêgo, Maria de Fátima Paiva Baracho, Maria Goretti do Nascimento Santos, Eryvaldo Sócrates Tabosa do Egito, José Brandão Neto.   

Abstract

BACKGROUND: Berardinelli-Seip syndrome (BSS) or Generalized Congenital Lipodystrophy often affects the cardiovascular system and also promotes metabolic abnormalities involving glycidic and lipid metabolisms.
OBJECTIVE: To assess the prevalence of cardiometabolic abnormalities in patients with BSS.
METHODS: Twenty-two patients from the state of Rio Grande do Norte, Brazil, diagnosed with BSS, underwent clinical evaluation, resting electrocardiogram, echodopplercardiogram, chest X-ray, 24-hour ambulatory electrocardiogram monitoring, exercise testing and laboratory analysis.
RESULTS: The patients were predominantly young adults, most of whom women. The whole sample showed insulin resistance, acanthosis nigricans and diminished HDL-cholesterol. The presence of splenomegaly, hepatomegaly, type II diabetes and elevated triglycerides was constant. Metabolic syndrome was characterized in most patients, which were predominantly women and with a high degree of paternal consanguinity. SAH and prehypertension blood pressure were found in more than half of the patients (77.3%). The echodopplercardiogram showed the presence of CLVH (50%), eccentric left ventricular hypertrophy (4.5%), and normal left ventricular geometry (45.5%). High arrhythmia rates were observed by Holter monitoring, such as ventricular ectopic beats, supraventricular ectopic beats and sustained supraventricular tachycardia. Chronotropic incompetence (54.5%) was observed during exercise testing.
CONCLUSION: A high prevalence of cardiovascular and metabolic abnormalities was observed in young asymptomatic individuals with BSS. These findings point to the need for systematic cardiological follow-up and of preventive measures in this high-risk group.

Entities:  

Mesh:

Year:  2010        PMID: 20414534     DOI: 10.1590/s0066-782x2010000100017

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  8 in total

Review 1.  Congenital generalized lipodystrophies--new insights into metabolic dysfunction.

Authors:  Nivedita Patni; Abhimanyu Garg
Journal:  Nat Rev Endocrinol       Date:  2015-08-04       Impact factor: 43.330

2.  Early commitment of cardiovascular autonomic modulation in Brazilian patients with congenital generalized lipodystrophy.

Authors:  Clarisse Mourão Melo Ponte; Virgínia Oliveira Fernandes; Maria Helane Costa Gurgel; Izabella Tamira Galdino Farias Vasconcelos; Lia Beatriz de Azevedo Souza Karbage; Christiane Bezerra Rocha Liberato; Carlos Antônio Negrato; Marília de Brito Gomes; Ana Paula Dias Rangel Montenegro; Renan Magalhães Montenegro Júnior
Journal:  BMC Cardiovasc Disord       Date:  2018-01-12       Impact factor: 2.298

3.  Association between cardiovascular autonomic neuropathy and left ventricular hypertrophy in young patients with congenital generalized lipodystrophy.

Authors:  Clarisse Mourão Melo Ponte; Virgínia Oliveira Fernandes; Christiane Bezerra Rocha Liberato; Ana Paula Dias Rangel Montenegro; Lívia Aline Batista; Maria Helane Costa Gurgel; Lia Beatriz de Azevedo Karbage; Izabella Tamira Galdino Farias Vasconcelos; Catarina Brasil d'Alva; Renan Magalhães Montenegro Júnior
Journal:  Diabetol Metab Syndr       Date:  2019-07-01       Impact factor: 3.320

4.  Impaired functional exercise capacity and greater cardiovascular response to the 6-min walk test in congenital generalized lipodystrophy.

Authors:  Jorge Luiz Dantas de Medeiros; Bruno Carneiro Bezerra; Helen Rainara Araújo Cruz; Katarina Azevedo de Medeiros; Maria Eduarda Cardoso de Melo; Aquiles Sales Craveiro Sarmento; Marcela Abbott Galvão Ururahy; Lucymara Fassarella Agnez Lima; Alcebíades José Dos Santos Neto; Josivan Gomes Lima; Vanessa Resqueti; Lucien Peroni Gualdi; Guilherme Fregonezi; Julliane Tamara Araújo de Melo Campos
Journal:  BMC Cardiovasc Disord       Date:  2022-08-25       Impact factor: 2.174

5.  Nurses' knowledge about Berardinelli-Seip Congenital Lipodystrophy.

Authors:  Verônica Kristina Cândido Dantas; Joice da Silva Soares; Lázaro Batista de Azevedo Medeiros; Aquiles Sales Craveiro Sarmento; Thaiza Teixeira Xavier Nobre; Fábia Barbosa de Andrade; Josivan Gomes de Lima; Julliane Tamara Araújo de Melo Campos
Journal:  PLoS One       Date:  2018-06-04       Impact factor: 3.240

6.  Impairment of respiratory muscle strength in Berardinelli-Seip congenital lipodystrophy subjects.

Authors:  Jorge Luiz Dantas de Medeiros; Bruno Carneiro Bezerra; Thiago Anderson Brito de Araújo; Aquiles Sales Craveiro Sarmento; Lázaro Batista de Azevedo Medeiros; Lucien Peroni Gualdi; Maria do Socorro Luna Cruz; Thaiza Teixeira Xavier Nobre; Josivan Gomes Lima; Julliane Tamara Araújo de Melo Campos
Journal:  Respir Res       Date:  2018-09-12

Review 7.  Recent advances in understanding lipodystrophy: a focus on lipodystrophy-associated cardiovascular disease and potential effects of leptin therapy on cardiovascular function.

Authors:  Thiago Bruder-Nascimento; Taylor C Kress; Eric J Belin de Chantemele
Journal:  F1000Res       Date:  2019-10-16

Review 8.  Cardiac Alterations in Patients with Familial Lipodystrophy.

Authors:  Minna Moreira Dias Romano; Paula Ananda Inês Chacon; Fernanda Naira Zambelli Ramalho; Maria Cristina Foss; André Schmidt
Journal:  Arq Bras Cardiol       Date:  2020-02       Impact factor: 2.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.